CMS, Pharma Discuss Negotiation Guide; PBM Hearings On Tap; USPTO Pressed On Patent Thickets; HRSA Sends 340B Letters

By Gabrielle Wanneh / March 27, 2023 at 6:31 PM
CMS and drug companies met Monday afternoon (March 27) to discuss the agency’s new guidance on how Medicare drug price negotiation will be implemented, including how CMS will select negotiation-eligible drugs and make its initial price offers. On Capitol Hill, House and Senate committees will hold hearings on pharmacy benefit manager reforms, after the Senate Commerce Committee passed PBM transparency legislation last week. The committees will hear testimony on issues surrounding PBM transparency, drug industry competition, and the impact of...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.